title: Identification of patients at high risk of chemotherapy-induced toxicity in small-cell lung cancer.
authors.affiliation: Department of Clinical Oncology, University College and Middlesex School of Medicine, Faculty of Clinical Sciences, London, England.
authors.forename: R L
authors.initials: RL
authors.lastname: Souhami
authors.forename: L
authors.initials: L
authors.lastname: Morittu
authors.forename: C M
authors.initials: CM
authors.lastname: Ash
authors.forename: H
authors.initials: H
authors.lastname: Earl
authors.forename: D
authors.initials: D
authors.lastname: Geddes
authors.forename: P G
authors.initials: PG
authors.lastname: Harper
authors.forename: J S
authors.initials: JS
authors.lastname: Tobias
authors.forename: S G
authors.initials: SG
authors.lastname: Spiro
mesh_terms: D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012709:Serum Albumin / Q000378:metabolism; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D012709:Serum Albumin; D000469:Alkaline Phosphatase